Imo the reason $50M is on the LOW side is any drug
that has multiple targets always get's a premium.
Whoever is partnering w' Brilacidin is looking at it as a
franchise that wants to be involved in all targets,hence
higher premium multi royalty drug.
Cheers'
that has multiple targets always get's a premium.
Whoever is partnering w' Brilacidin is looking at it as a
franchise that wants to be involved in all targets,hence
higher premium multi royalty drug.
Cheers'
5